Gabelli Funds’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-828,055
| Closed | -$82.2M | – | 1199 |
|
|
2019
Q3 | $82.2M | Buy |
828,055
+31,630
| +4% | +$3.01M | 0.54% | 32 |
|
|
2019
Q2 | $73.6M | Buy |
796,425
+211,098
| +36% | +$20M | 0.47% | 45 |
|
|
2019
Q1 | $55.2M | Buy |
+585,327
| New | +$51.2M | 0.35% | 77 |
|
|
2017
Q4 | – | Sell |
-44,900
| Closed | -$6.55M | – | 1165 |
|
|
2017
Q3 | $6.55M | Buy |
44,900
+3,000
| +7% | +$409K | 0.04% | 505 |
|
|
2017
Q2 | $5.44M | Sell |
41,900
-14,000
| -25% | -$1.72M | 0.03% | 537 |
|
|
2017
Q1 | $6.96M | Buy |
55,900
+13,300
| +31% | +$1.59M | 0.04% | 471 |
|
|
2016
Q4 | $4.93M | Sell |
42,600
-26,000
| -38% | -$2.9M | 0.03% | 553 |
|
|
2016
Q3 | $7.17M | Buy |
68,600
+2,700
| +4% | +$292K | 0.04% | 459 |
|
|
2016
Q2 | $6.5M | Buy |
65,900
+11,000
| +20% | +$1.14M | 0.04% | 478 |
|
|
2016
Q1 | $5.5M | Sell |
54,900
-11,500
| -17% | -$1.18M | 0.03% | 524 |
|
|
2015
Q4 | $7.95M | Hold |
66,400
| – | – | 0.05% | 435 |
|
|
2015
Q3 | $7.18M | Buy |
66,400
+19,000
| +40% | +$2.36M | 0.04% | 467 |
|
|
2015
Q2 | $5.49M | Hold |
47,400
| – | – | 0.03% | 561 |
|
|
2015
Q1 | $5.46M | Sell |
47,400
-2,200
| -4% | -$263K | 0.03% | 567 |
|
|
2014
Q4 | $5.55M | Sell |
49,600
-7,800
| -14% | -$823K | 0.03% | 571 |
|
|
2014
Q3 | $5.44M | Buy |
57,400
+3,000
| +6% | +$271K | 0.03% | 574 |
|
|
2014
Q2 | $4.67M | Buy |
54,400
+4,000
| +8% | +$304K | 0.02% | 617 |
|
|
2014
Q1 | $3.52M | Hold |
50,400
| – | – | 0.02% | 659 |
|
|
2013
Q4 | $4.26M | Sell |
50,400
-3,200
| -6% | -$253K | 0.02% | 602 |
|
|
2013
Q3 | $4.13M | Hold |
53,600
| – | – | 0.02% | 599 |
|
|
2013
Q2 | $3.13M | Buy |
+53,600
| New | +$3.23M | 0.02% | 627 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Gabelli Funds's CELG Position: Q4 2019 in Review
Gabelli Funds sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 828,055 shares — an estimated $82.2M sold.
Gabelli Funds first reported a position in CELG in Q2 2013 and held it in 21 quarters. The position peaked at $82.2M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Gabelli Funds reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Gabelli Funds sold 828,055 Celgene Corp shares in Q4 2019, an estimated $82.2M.
- Gabelli Funds first reported a position in Celgene Corp in Q2 2013 and held it in 21 quarters.
- Gabelli Funds's Celgene Corp position peaked at $82.2M in Q3 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Gabelli Funds's 13F filing for Q4 2019, filed 14 Feb 2020.